Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach

Total article views   HTML views PDF downloads Totals
4,362 Dovepress* 4,058+ 1,077 5,135
PubMed Central* 304 111 415
Totals 4,362 1,188 5,550
*Since 16 April 2020

View citations on PubMed Central and Google Scholar